These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15930999)

  • 1. Role of fibroblast growth factor 23 in health and in chronic kidney disease.
    Fukagawa M; Nii-Kono T; Kazama JJ
    Curr Opin Nephrol Hypertens; 2005 Jul; 14(4):325-9. PubMed ID: 15930999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
    Liu S; Gupta A; Quarles LD
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
    Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
    Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF23 and Bone and Mineral Metabolism.
    Fukumoto S
    Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF23 and syndromes of abnormal renal phosphate handling.
    Bergwitz C; Jüppner H
    Adv Exp Med Biol; 2012; 728():41-64. PubMed ID: 22396161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in understanding of phosphate homeostasis and related disorders.
    Michigami T
    Endocr J; 2022 Aug; 69(8):881-896. PubMed ID: 35831119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
    Prié D; Friedlander G
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into phosphate homeostasis: fibroblast growth factor 23 and frizzled-related protein-4 are phosphaturic factors derived from tumors associated with osteomalacia.
    Kumar R
    Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):547-53. PubMed ID: 12187320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 23 (FGF23) and the kidney.
    Tsagalis G; Psimenou E; Manios E; Laggouranis A
    Int J Artif Organs; 2009 Apr; 32(4):232-9. PubMed ID: 19569031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic diseases of renal phosphate handling.
    Wagner CA; Rubio-Aliaga I; Biber J; Hernando N
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv45-54. PubMed ID: 25165185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?
    Razzaque MS
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F470-6. PubMed ID: 19019915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.
    Liu S; Tang W; Zhou J; Stubbs JR; Luo Q; Pi M; Quarles LD
    J Am Soc Nephrol; 2006 May; 17(5):1305-15. PubMed ID: 16597685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D and type II sodium-dependent phosphate cotransporters.
    Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
    Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.
    Kolek OI; Hines ER; Jones MD; LeSueur LK; Lipko MA; Kiela PR; Collins JF; Haussler MR; Ghishan FK
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1036-42. PubMed ID: 16020653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone-kidney axis in systemic phosphate turnover.
    Razzaque MS
    Arch Biochem Biophys; 2014 Nov; 561():154-8. PubMed ID: 24997362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of bone in phosphate metabolism.
    Fukumoto S
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):63-70. PubMed ID: 18822343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 23 and its receptors.
    Yu X; White KE
    Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications.
    Damasiewicz MJ; Toussaint ND; Polkinghorne KR
    Nephrology (Carlton); 2011 Mar; 16(3):261-8. PubMed ID: 21265930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF23: its role in renal bone disease.
    Fukagawa M; Kazama JJ
    Pediatr Nephrol; 2006 Dec; 21(12):1802-6. PubMed ID: 16932898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.